Related Experiment Video
Updated: May 24, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Management of critically ill patients difficult to sedate: Update and clinical strategies
Diana Gil-Castillejos1, Aaron Castanera-Duro2, Gemma Via-Clavero3
1Área del Paciente Crítico, Hospital Universitari de Tarragona Joan XXIII, Departamento de Enfermería, Universitat Rovira i Virgili, Tarragona, Spain; Grupo de Trabajo de Analgesia, Sedación, Contenciones y Delirio de la Sociedad Española de Enfermería Intensiva y Unidades Coronarias (GT-ASCyD-SEEIUC), Spain.
Abstract:
One in every three critically ill patients who receive prolonged analgosedation may experience difficult sedation, negatively influencing their evolution and prognosis. Difficult sedation includes situations of therapeutic failure, tolerance or deprivation of analgesic and sedative drugs. Its origin is multifactorial and depends on the patient's characteristics, history of drug consumption, critical condition and the administration of drugs that alter the pharmacokinetics of the sedatives used. This update aims to describe the definition of difficult sedation, identify the group of critically ill sedated patients who can develop it, its etiology, and how it should be treated and managed. The difficulty in achieving an adequate level of sedation, increasing the dose of sedatives or adding new agents represents a challenge in daily practice in critical care units since it can increase the risks of toxicity and related complications. Prevention and early identification of difficult sedation situations are essential strategies to minimize their impact; hence nurses' autonomy in the management of analgosedation represents a primary intervention.
More Related Videos
Related Concept Videos
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Stages of General Anesthesia
Sedatives and Hypnotics Drugs: Barbiturates
Parenteral Anesthetics: Overview
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Management of Insomnia

